Tong Y - Search Results

1

Short-term outcomes of the over-the-scope clip proctology system for rectovaginal fistula repair: a prospective study.

Tong Y, Trilling B, Sage PY, Girard E, Faucheron JL. Tong Y, et al. Tech Coloproctol. 2019 Mar;23(3):245-249. doi: 10.1007/s10151-019-01948-5. Epub 2019 Apr 1. Tech Coloproctol. 2019. PMID: 30937645

2

IGF-1 Interacted With Obesity in Prognosis Prediction in HER2-Positive Breast Cancer Patients.

Tong Y, Wu J, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. Tong Y, et al. Front Oncol. 2020 Apr 24;10:550. doi: 10.3389/fonc.2020.00550. eCollection 2020. Front Oncol. 2020. PMID: 32391265 Free PMC article.

3

Association of Biomarker Discrepancy and Treatment Decision, Disease Outcome in Recurrent/Metastatic Breast Cancer Patients.

Lu Y, Tong Y, Chen X, Shen K. Lu Y, et al. Among authors: tong y. Front Oncol. 2021 Jul 1;11:638619. doi: 10.3389/fonc.2021.638619. eCollection 2021. Front Oncol. 2021. PMID: 34277399 Free PMC article.

4

Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients.

Lu Y, Tong Y, Huang J, Lin L, Wu J, Fei X, Huang O, He J, Zhu L, Chen W, Li Y, Chen X, Shen K. Lu Y, et al. Among authors: tong y. Front Oncol. 2020 Jul 31;10:1315. doi: 10.3389/fonc.2020.01315. eCollection 2020. Front Oncol. 2020. PMID: 32850415 Free PMC article.

5

Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial.

Huang J, Tong Y, Hong J, Huang O, Wu J, He J, Chen W, Li Y, Chen X, Shen K. Huang J, et al. Among authors: tong y. Breast Cancer Res Treat. 2023 Feb;197(3):525-533. doi: 10.1007/s10549-022-06821-y. Epub 2022 Dec 16. Breast Cancer Res Treat. 2023. PMID: 36525180 Clinical Trial.

6

Comprehensive Association Analysis of 21-Gene Recurrence Score and Obesity in Chinese Breast Cancer Patients.

Tong Y, Gao W, Wu J, Zhu S, Huang O, He J, Zhu L, Chen W, Li Y, Shen K, Chen X. Tong Y, et al. Front Oncol. 2021 Mar 26;11:619840. doi: 10.3389/fonc.2021.619840. eCollection 2021. Front Oncol. 2021. PMID: 33842323 Free PMC article.

7

Insulin-like growth factor-1, metabolic abnormalities, and pathological complete remission rate in HER2-positive breast cancer patients receiving neoadjuvant therapy.

Tong YW, Wang G, Wu JY, Huang O, He JR, Zhu L, Chen WG, Li YF, Chen XS, Shen KW. Tong YW, et al. Onco Targets Ther. 2019 May 21;12:3977-3989. doi: 10.2147/OTT.S194981. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190894 Free PMC article.

8

Accuracy of ultrasonographic changes during neoadjuvant chemotherapy to predict axillary lymph node response in clinical node-positive breast cancer patients.

Li Z, Tong Y, Chen X, Shen K. Li Z, et al. Among authors: tong y. Front Oncol. 2022 Jul 22;12:845823. doi: 10.3389/fonc.2022.845823. eCollection 2022. Front Oncol. 2022. PMID: 35936729 Free PMC article.

9

Association of machine learning ultrasound radiomics and disease outcome in triple negative breast cancer.

Wang H, Li X, Yuan Y, Tong Y, Zhu S, Huang R, Shen K, Guo Y, Wang Y, Chen X. Wang H, et al. Among authors: tong y. Am J Cancer Res. 2022 Jan 15;12(1):152-164. eCollection 2022. Am J Cancer Res. 2022. PMID: 35141010 Free PMC article.

10

Association of Obesity and Luminal Subtypes in Prognosis and Adjuvant Endocrine Treatment Effectiveness Prediction in Chinese Breast Cancer Patients.

Tong Y, Zhu S, Chen W, Chen X, Shen K. Tong Y, et al. Front Oncol. 2022 May 5;12:862224. doi: 10.3389/fonc.2022.862224. eCollection 2022. Front Oncol. 2022. PMID: 35600356 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,258 results

Search Page

Filters